Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice

Cancer Research

Volumn 64, Issue 1, 2004, Pages 378-385

  Lozupone, Francesco ^a   Pende, Daniela ^b   Burgio, Vito Lelio ^c   Castelli, Chiara ^d   Spada, Massimo ^a   Venditti, Massimo ^a   Luciani, Francesca ^a   Lugini, Luana ^a   Federici, Cristina ^a   Ramoni, Carlo ^a   Rivoltini, Licia ^d   Parmiani, Giorgio ^d   Belardelli, Filippo ^a   Rivera, Paola ^f   Marcenaro, Stefania ^e   Moretta, Lorenzo ^e,f   Fais, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOGRAFT; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; IMMUNOTHERAPY; IN VIVO STUDY; INOCULATION; LYMPHOID CELL; MELANOMA; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE; TUMOR GROWTH; TUMOR LOCALIZATION; XENOGRAFT;

ANIMALS; ANTIGENS, CD; CELL DIVISION; DNA; FEMALE; HUMANS; KILLER CELLS, NATURAL; MELANOMA; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 9144261113     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1501     Document Type: Article

References (49)

1. Trinchieri, G. Biology of natural killer cells. Adv. Immunol., 47: 187-376, 1990.
2. Soloski, M., J. Recognition of tumor cells by the innate immune system. Curr. Opin. Immunol., 13: 154-162, 2001.
3. Ferrarini, M., Ferrero, E., Dagna, L., Poggi, A., and Zocchi, M. R. Human γδ T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol., 23: 14-18, 2002.
4. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., and Moretta, L. Receptors for HLA-class I molecules in human natural killer cells. Annu. Rev. Immunol., 14: 619-648, 1996.
5. Long, E. O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol., 17: 875-904, 1998.
6. Lanier, L. L. Turning on natural killer cells. J. Exp. Med., 191: 1259-1262, 2000.
7. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., and Moretta, L. Activating receptors and coreceptors involved in Natural Cytotoxicity. Annu. Rev. Immunol., 19: 197-223, 2001.
8. Bauer, S., Groh, V., Wu, J., Steinle, A., Philips, J. H., Lanier, L. L., and Spies, T. Activation of NK cells and T cells by NKG2D, a receptor for stress inducible-MICA. Science (Wash. DC), 285: 727-729, 1999.
9. Pende, D., Rivera, P., Marcenaro, S., Chang, C. C., Biassoni, R., Conte, R., Kubin, M., Cosman, D., Ferrone, S., Moretta, L., and Moretta, A. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res., 62: 6178-6186, 2002.
10. Li, P., Morris, D. L., Willcox, B. E., Steinle, A., Spies, T., and Strong, R. K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol., 2: 443-451, 2001.
11. Cosmam, D., Mulberg, J., Sutherland, C., Chin, W., Armitage, R., Fanslow, W., Kubin, M., and Chalupny, J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 14: 123-133, 2001.
12. Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., and Spies, T. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA, 96: 6878-6884, 1999.
13. Triebel, F. and Hercend, T. Subpopulations of human peripheral T γ δ lymphocytes. Immunol. Today, 10: 186-188, 1989.
14. Hayday, A. C. γδ cells: a right time and a right place for a converted third way of protection. Annu. Rev. Immunol., 18: 975-1026, 2000.
15. Deusch, K., Luling, F., Reich, K., Classen, M., Wagner, H., and Pfeffer, K. A major fraction of human intraepithelial lymphocytes simultaneously expresses the γ/δ T cell receptor, the CD8 accessory molecule and preferentially uses the V δ I gene segment. Eur. J. Immunol., 4: 1053-1059, 1991.
16. Das, H., Groh, V., Kuijl, C., Sugita, M. Morita, C. T., Spies, T., and Bukowski, J. F. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity, 15: 83-93, 2001.
17. Wu, J., Groh, V., and Spies, T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC Class I-Related Chains by epithelial γδ T cells. J. Immunol., 169: 1236-1240, 2002.
18. Kuppen, P. J., Gorter, A., Hagenaars, M., Jonges, L. E. Giezeman-Smits, K. M., Nagelkerke, J. F., Fleuren, G., and van de Velde, C. J. Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model. Immunol. Rev., 184: 236-243, 2001.
19. Basse, P. H., Whiteside, T. L., Chambers, W., and Herberman, R. B. Therapeutic activity of NK cells against tumors. Int. Rev. Immunol., 20: 439-501, 2001.
20. Whiteside, T. L., Vujanovic, N. L., and Herberman, R. B. Natural killer cells and tumor therapy. Curr. Top. Microbiol. Immunol., 230: 221-244, 1998.
21. Tonn, T., Becker, S., Esser, R., Schwabe, D., and Seifried, E. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J. Hematother. Stem. Cell Res., 10: 535-544, 2001.
22. Fehniger, T. A., Blumam, E. M., Porter, M. M., Mrozek, E., Cooper, M. A., VanDeusen, J. B., Frankel, S. R., Stock, W., and Caligiuri, M. A. Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J. Clin. Investig., 106: 117-124, 2000.
23. Ruggeri, L., Canni, M., Urbani, E., Perruccio, K., Shlomchick, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M. F., and Velardi, A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (Wash. DC), 295: 2097-2100, 2002.
24. Velardi, A., Ruggeri, L., Moretta, A., and Moretta, L. N. K. cells: A lesson from mismatched hematopoietic transplantation. Trends Immunol., 23: 438-444, 2002.
25. Moris, A., Rothenfusser, S., Meuer, E., Hangretinger, R., and Fisch, P. Role of γδ T cells in tumor immunity and their control by NK receptors. Microbes Infect., 1: 227-234, 1999.
26. Maeurer, M. J., Martin, D., Walter, W., Liu, K., Zitvogel, L., Halusczcak, K., Rabinowich, H., Duquesnoy, R., Storkus, W., and Lotze, M. T. Human intestinal Vδ1 + lymphocytes recognize tumor cells of epithelial origin. J. Exp. Med., 183: 1681-1696, 1996.
27. Ferrarini, M., Heltai, S., Pupa, S. M., Mernard, S., and Zocchi, R. Killing of lamininreceptor-positive human lung cancers by tumorinfiltrating lymphocytes bearing γδ+ T-cell receptors. J. Natl. Cancer Inst., 294: 436-441, 1996.
28. Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., and Sutton, B. Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by γδ T cells. Science (Wash. DC), 294: 605-609, 2001.
29. Bankert, R. B., Egilmez, N. K., and Hess, S. D. Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol., 22: 386-393, 2001.
30. Takahashi, H., Nakada, T., and Puisieux, I. Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science (Wash. DC), 259: 1460-1463, 1993.
31. Hill, L. L., Perussia, B., McCue, P. A., and Korngold, R. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res., 54: 763-770, 1994.
32. Tam, Y. K., Miyagawa, B., Ho, V. C., and Klingemann, H. G. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J. Hematother., 8: 281-290, 1999.
33. Nokihara, H., Yanagawa, H., Nishioka, Y., Yano, S., Mukaida, N., Matsushima, K., and Sone, S. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res., 60: 7002-7007, 2000.
34. Multhoff, G., Pfister, K., Botzler, C., Jordan, A., Scholz, R., Schmetzer, H., Burgstahler, R., and Hiddemann, W. Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors. Int. J. Cancer, 88: 791-797, 2000.
35. Malkovska, V., Cigel, F. K., Armstrong, N., Storer, B. E., and Hong, R. Antilymphoma activity of human γ δ T-cells in mice with severe combined immune deficiency. Cancer Res., 52: 5610-5616, 1992.
36. Malkovska, V., Cigel, F., and Storer, B. E. Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity. Clin. Exp. Immuno., 96: 158-165, 1994.
37. Winn, H., J. Immune mechanisms in homotransplantation. II Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J. Immunol., 84: 228-239, 1960.
38. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
39. Pende, D., Accame, L., Pareti, L., Mazzocchi, A., Moretta, A., Parmiani, G., and Moretta, L. The susceptibility to natural killer cell-mediated lysis of HLA class 1-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. Eur. J. Immunol., 28: 2384-2394, 1998.
40. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., Bottino, C., Moretta, L., and Moretta, A. Identification and molecular characterization of NKp30. a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med., 190: 1505-1516, 1999.
41. Ciccone, E., Ferrini, S., Bottino, C., Viale, O., Prigione, I., Pantalco, G., Tambussi, G., Moretta, A., and Moretta, L. A monoclonal antibody specific for a common determinant of the human TCR directly activates CD3+WT31- lymphocytes to express their functional program(s). J. Exp. Med., 168: 1-11, 1998.
42. Ferrini, S., Prigione, I., Bottino, C., Ciccone, E., Tambussi, G., Mammoliti, S., Moretta, L., and Moretta, A. Monoclonal antibodies which react with the T cell receptor γ/δ recognize different subsets of CD3+WT31- T lymphocytes. Eur. J. Immunol., 19: 57-61, 1989.
43. Lozupone, F., Luciani, F., Venditti, M., Rivohini, L., Pupa, S., Parmiani, G., Belardelli, F., and Fais, S. Murine granulocytes control human tumor growth in SCID mice. Int. J. Cancer, 87: 569-573, 2000.
44. Rizza, P., Santini, S. M., Logozzi, M. A., Lapenta, C., Scstili, P., Ghepardi, G., Lande, R., Spada, M., Parlato, S., Belardelli, F., and Fais, S. T cell dysfunctions in hu-PBL-SCID mice infected with HIV-1 shortly after reconstitution. The in vivo effects of HIV on highly activated immune cells. J. Virol., 70: 7958-7964, 1996.
45. Iwanuma, Y., Chen, F. A., Egilmez, N. K., Takita, H., and Bankert, R. B. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice. Cancer Res., 57: 2937-2942, 1997.
46. Murre, C. Interiwining proteins in thymocyte development and cancer. Nat. Immunol., 1: 97-98, 2000.
47. Janeway, C. A., Jr., Jones, B., and Hayday, A. Specificity and function of T cells bearing γ δ receptors. Immunol. Today, 9: 73-76, 1988.
48. Holtmeier, W., Pfander, M., Hennemann, A., Zollner, T. M., Kaufmann, R., and Caspary, W. F. The TCR-δ repertoire in normal human skin is restricted and distinct from the TCR-δ repertoire in the peripheral blood. J. Investig. Dermatol., 116: 275-280, 2001.
49. + T cell clone leads to immunoselection to human melanoma antigen-loss variants in SCID mice. Eur J. Immunol., 33: 556-566, 2003.